Variation in protection by BCG: implications of and for heterologous immunity
- 1 November 1995
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 346 (8986) , 1339-1345
- https://doi.org/10.1016/s0140-6736(95)92348-9
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- A contact study to evaluate the BCG vaccination programme in SeoulTubercle, 1989
- Effectiveness of BCG vaccination in england and wales in 1983Tubercle, 1987
- The effect of oral mycobacterium vaccae on subsequent responses of mice to BCG sensitizationTubercle, 1985
- Species level identification of non-tuberculous mycobacteria from South Indian BCG trial area during 1981Tubercle, 1985
- Childhood tuberculosis in SwedenTubercle, 1983
- The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCGTubercle, 1981
- Effectiveness of BCG vaccination in Great Britain in 1978: A report from the research committee of the British thoracic associationRespiratory Medicine, 1980
- Present effectiveness of BCG vaccination in England and Wales A report from the Research Committee of the British Thoracic and Tuberculosis AssociationTubercle, 1975
- The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccinesTubercle, 1967
- BCG vaccination of Indian infants in Saskatchewan: A study carried out with financial assistance from the National Research Council of CanadaTubercle, 1949